Salus - Public Comps and Valuation Multiples

Salus Overview

About Salus

Salus is a Slovenia-based company engaged in the wholesale and distribution of medical products. It offers medicines, medical devices, medical supplies, dietary supplements, cosmetics to hospitals, pharmacies, and other customers.

Founded

1969

HQ

Employees

413

Website

salus.si

Sectors

Medical Supplies

Financials

Last FY Revenue $757M

Last FY EBITDA $29.9M

EV

$507M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Salus Financials

See Salus valuation multiples based on analyst estimates

Salus P&L

In the most recent fiscal year, Salus reported revenue of $757M and EBITDA of $29.9M.

Salus expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Salus valuation multiples based on analyst estimates

	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	XXX	$757M	XXX	XXX	XXX
Gross Profit	XXX	$85.7M	XXX	XXX	XXX
Gross Margin	XXX	11%	XXX	XXX	XXX
EBITDA	XXX	$29.9M	XXX	XXX	XXX
EBITDA Margin	XXX	4%	XXX	XXX	XXX
EBIT	XXX	$19.5M	XXX	XXX	XXX
EBIT Margin	XXX	3%	XXX	XXX	XXX
Net Profit	XXX	$15.0M	XXX	XXX	XXX
Net Margin	XXX	2%	XXX	XXX	XXX
Net Debt	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Salus including revenue, profitability, and margin analysis across different time periods. In the most recent fiscal year, Salus achieved $757M in revenue and $29.9M in EBITDA.
Financial Metric	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	Analyst estimates available to subscribers	$757M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	Analyst estimates available to subscribers	$85.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	Analyst estimates available to subscribers	11.3% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	Analyst estimates available to subscribers	$29.9M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	Analyst estimates available to subscribers	3.9% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	Analyst estimates available to subscribers	$19.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	Analyst estimates available to subscribers	2.6% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	Analyst estimates available to subscribers	$15.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	Analyst estimates available to subscribers	2.0% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Salus

This financial data table provides comprehensive performance metrics for Salus, a company based in Slovenia. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Fiscal Year Performance

In the most recent fiscal year, Salus reported $757M in total revenue.
Fiscal year EBITDA was $29.9M.
The company maintained a gross profit margin of 11.3% in the most recent fiscal year.
EBITDA margin for the fiscal year was 3.9%.
Net profit margin reached 2.0% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Salus. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Salus Stock Performance

Salus has current market cap of EUR 419M (or $489M), and EV of EUR 435M (or $507M).

Market Cap Evolution

Salus Stock Data

As of October 3, 2025, Salus's stock price is EUR 51 (or $59).

See Salus trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$507M	$489M	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Salus Valuation Multiples

Salus's trades at 0.7x EV/Revenue multiple, and 17.0x EV/EBITDA.

See valuation multiples for Salus and 15K+ public comps

Salus Financial Valuation Multiples

As of October 3, 2025, Salus has market cap of $489M and EV of $507M.

Equity research analysts estimate Salus's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Salus's P/E ratio is not available.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$489M	XXX	$489M	XXX	XXX	XXX
EV (current)	$507M	XXX	$507M	XXX	XXX	XXX
EV/Revenue	n/a	XXX	0.7x	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	17.0x	XXX	XXX	XXX
EV/EBIT	n/a	XXX	25.9x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	n/a	XXX	32.6x	XXX	XXX	XXX
EV/FCF	n/a	XXX	54.5x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Salus Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Salus Margins & Growth Rates

Salus's revenue per employee in the last FY averaged $1.8M, while opex per employee averaged $0.2M for the same period.

Salus's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Salus's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Salus and other 15K+ public comps

Salus Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	4%	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	n/a	XXX	XXX	XXX
Rule of 40	n/a	XXX	n/a	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	n/a	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$1.8M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	6%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	9%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial